Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intracameral implant) in Conjunction with Cataract Surgery vs. Cataract Surgery Alone
Research payments
$590,773
Through program year 2025, $590,773 in research payments was reported against Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intracameral implant) in Conjunction with Cataract Surgery vs. Cataract Surgery Alone, across 49 payments, paid by Glaukos Corporation.
- Paid by
- Glaukos Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $590,773 | 49 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Berdahl Sioux Falls, SD Named on 8 payments
- Sebastian Heersink Dothan, AL Named on 8 payments
- George Reiss Glendale, AZ Named on 7 payments
- Fiaz Zaman Houston, TX Named on 7 payments
- Inder Singh Racine, WI Named on 7 payments
- Craig Mitcham Dayton, OH Named on 4 payments
- Kevin Talbot Beaumont, TX Named on 3 payments
- Michael Greenwood Sioux Falls, SD Named on 3 payments
- Joseph Gira Des Peres, MO Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.